Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JAB-3312 |
Trade Name | |
Synonyms | JAB3312|JAB 3312 |
Drug Descriptions |
JAB-3312 is a SHP2 inhibitor, which potentially decreases tumor growth (Ann Oncol (2023) 34 (suppl_2): S459). |
DrugClasses | SHP2 Inhibitor 20 |
CAS Registry Number | NA |
NCIT ID | C164218 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Binimetinib + JAB-3312 | Binimetinib JAB-3312 | 0 | 1 |
Glecirasib + JAB-3312 | Glecirasib JAB-3312 | 0 | 0 |
JAB-3312 | JAB-3312 | 0 | 0 |
JAB-3312 + Pembrolizumab | JAB-3312 Pembrolizumab | 0 | 1 |